These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38754401)

  • 21. Association of Combined Complement Factor H Y402H and ARMS/LOC387715 A69S Polymorphisms with Age-related Macular Degeneration: A Meta-analysis.
    Jabbarpoor Bonyadi MH; Yaseri M; Bonyadi M; Soheilian M; Karimi S
    Curr Eye Res; 2016 Dec; 41(12):1519-1525. PubMed ID: 27269047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration.
    Smailhodzic D; Muether PS; Chen J; Kwestro A; Zhang AY; Omar A; Van de Ven JP; Keunen JE; Kirchhof B; Hoyng CB; Klevering BJ; Koenekoop RK; Fauser S; den Hollander AI
    Ophthalmology; 2012 Nov; 119(11):2304-11. PubMed ID: 22840423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT).
    Hagstrom SA; Ying GS; Pauer GJT; Sturgill-Short GM; Huang J; Callanan DG; Kim IK; Klein ML; Maguire MG; Martin DF;
    Ophthalmology; 2013 Mar; 120(3):593-599. PubMed ID: 23337555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between high-risk disease loci and response to anti-vascular endothelial growth factor treatment for wet age-related macular degeneration.
    Orlin A; Hadley D; Chang W; Ho AC; Brown G; Kaiser RS; Regillo CD; Godshalk AN; Lier A; Kaderli B; Stambolian D
    Retina; 2012 Jan; 32(1):4-9. PubMed ID: 21878851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of
    Cebatoriene D; Vilkeviciute A; Gedvilaite-Vaicechauskiene G; Duseikaite M; Bruzaite A; Kriauciuniene L; Zaliuniene D; Liutkeviciene R
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Two Polymorphisms, rs1061170 and rs1410996, in Complement Factor H with Age-Related Macular Degeneration in an Asian Population: A Meta-Analysis.
    Wu M; Guo Y; Ma Y; Zheng Z; Wang Q; Zhou X
    Ophthalmic Res; 2016; 55(3):135-44. PubMed ID: 26727378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic associations of anti-vascular endothelial growth factor therapy response in age-related macular degeneration: a systematic review and meta-analysis.
    Wang Z; Zou M; Chen A; Liu Z; Young CA; Wang SB; Zheng D; Jin G
    Acta Ophthalmol; 2022 May; 100(3):e669-e680. PubMed ID: 34403208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of three common VEGF polymorphisms in the risk of age-related macular degeneration.
    Liu Y; Hou S; Lang W; Dai D; Wang Z; Ji X; Li K; Zhang X; Zou Y; Wang J
    Genet Test Mol Biomarkers; 2014 Apr; 18(4):245-52. PubMed ID: 24689893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patients.
    Park UC; Shin JY; McCarthy LC; Kim SJ; Park JH; Chung H; Yu HG
    Mol Vis; 2014; 20():1680-94. PubMed ID: 25558172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The pharmacogenomics of CFH Y402H and wet age-related macular degeneration].
    Chen LL; Chen YY
    Zhonghua Yan Ke Za Zhi; 2017 Feb; 53(2):144-147. PubMed ID: 28260367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of combined complement factor H Y402H and ARMS2/LOC387715 A69S polymorphisms with age-related macular degeneration: an updated meta-analysis.
    Jabbarpoor Bonyadi MH; Yaseri M; Soheilian M
    Ophthalmic Genet; 2020 Aug; 41(4):301-307. PubMed ID: 32406777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of CFH, LOC387715, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population.
    Xu Y; Guan N; Xu J; Yang X; Ma K; Zhou H; Zhang F; Snellingen T; Jiao Y; Liu X; Wang N; Liu N
    Mol Vis; 2008 Jul; 14():1373-81. PubMed ID: 18682812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Y402H polymorphism in complement factor H and age-related macular degeneration in the Tunisian population.
    Habibi I; Sfar I; Kort F; Aounallah-Skhiri H; Chebil A; Chouchene I; Bouraoui R; Limaiem R; Largheche L; Jendoubi-Ayed S; Makhlouf M; Ben Abdallah T; Ayed K; El Matri L; Gorgi Y
    Ophthalmic Res; 2013; 49(4):177-84. PubMed ID: 23306536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration.
    Feng X; Xiao J; Longville B; Tan AX; Wu XN; Cooper MN; McAllister IL; Isaacs T; Palmer LJ; Constable IJ
    Ophthalmology; 2009 Oct; 116(10):1908-12.e1. PubMed ID: 19692124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of CC-cytokine ligand 2 and complementary factor H Y402H polymorphisms and their interactional association with age-related macular degeneration.
    Bonyadi M; Foruzandeh Z; Mohammadian T; Fotouhi N; Soheilian M; Jabbarpoor Bonyadi MH; Javadzadeh A; Moein H; Yaseri M
    Acta Ophthalmol; 2016 Dec; 94(8):e779-e785. PubMed ID: 27316788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration.
    Lin JM; Wan L; Tsai YY; Lin HJ; Tsai Y; Lee CC; Tsai CH; Tseng SH; Tsai FJ
    Am J Ophthalmol; 2008 Jun; 145(6):1045-1051. PubMed ID: 18378209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration.
    Klein ML; Francis PJ; Rosner B; Reynolds R; Hamon SC; Schultz DW; Ott J; Seddon JM
    Ophthalmology; 2008 Jun; 115(6):1019-25. PubMed ID: 18423869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration.
    McKibbin M; Ali M; Bansal S; Baxter PD; West K; Williams G; Cassidy F; Inglehearn CF
    Br J Ophthalmol; 2012 Feb; 96(2):208-12. PubMed ID: 21558292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab.
    Lee AY; Raya AK; Kymes SM; Shiels A; Brantley MA
    Br J Ophthalmol; 2009 May; 93(5):610-3. PubMed ID: 19091853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics of the treatment response of age-related macular degeneration with ranibizumab and bevacizumab.
    Kanoff J; Miller J
    Semin Ophthalmol; 2013; 28(5-6):355-60. PubMed ID: 24010796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.